Navigation Links
Researchers identify novel pathophysiologic mechanism responsible for autoimmunity
Date:4/25/2011

(Boston) Researchers from Boston University School of Medicine (BUSM) have discovered that human proteins with an affinity for Dermatan Sulfate (DS) have the propensity to become autoantigens. In a companion article, the researchers also found that DS physically interacts with dead cells and that the resulting DSautoantigen complexes drive autoreactive B-1a cell responses and autoantibody production both in-vitro and in mouse models. These findings, which appear in two back-to-back papers in the May issue of the American Journal of Pathology, provide a promising tool for discovery of autoantigens, molecular diagnosis of autoimmune diseases and development of cause-specific therapies.

Autoimmune diseases are the third most common category of disease in the United States after cancer and heart disease; they affect approximately 14-22 million persons. Autoimmune diseases are among the most poorly understood medical conditions, although it is well accepted that they are caused by aberrant immune responses directed at endogenous molecules and tissues of the body. Autoimmune diseases encompass a wide spectrum of clinical presentations, and more than 80 types have been classified, based primarily on systemic or organ-specific involvement. Common systemic autoimmune diseases include systemic lupus erythematosus, rheumatoid arthritis and Sjgren's syndrome; localized diseases include type 1 diabetes, multiple sclerosis, and Graves' disease.

According to the researchers, both precise diagnosis and development of cause-directed therapies remain challenging. A major hurdle has been the lack of understanding of etiologically inciting molecular and cellular events and key pathophysiologic mechanisms that lead to autoimmunity.

Studying patients with autoimmune diseases, the researchers discovered patient-specific complex autoantigen patterns that were more diverse than previously thought, indicating significant pathological heterogeneity even within traditionally defined clinical entities, such as rheumatoid arthritis or systemic lupus erythematosus. By shotgun sequencing of DS affinity-enriched proteomes extracted from cell lines, they identified more than 200 autoantigens, both novel and previously linked to autoimmunity, including several well-known families of autoantigens related to the nucleosome, ribonucleoproteins, the cytoskeleton and heat shock proteins. We were able to capture the entire known human auotantigen-ome and then some more in a single experiment," explained senior author Michael Roehrl, MD, PhD, an assistant professor of pathology and laboratory medicine at BUSM.

The studies revealed that noncovalent DS-antigen complexes have the unique capability of expanding B-1a. "On the basis of our findings, we propose that DS forms complexes with autoantigens presented by apoptotic or dead cells and that these complexes promote the positive selection and expansion of autoreactive CD5_ B cells and the secretion of autoantibodies," he added.

"It has been a longstanding puzzle why only a small subset (1-2 percent) of all human proteins can become functional antibody targets in autoimmune diseases. Our theory offers a plausible answer to this ontogenic question central to autoimmunity by showing that affinity to DS may be a unifying principle of autoantigens," stated Roehrl.

The researchers believe that further investigation of the molecular activities of DS and DS-binding proteins will lead to a more precise understanding of the molecular mechanisms driving B-1a cell activation and thus autoimmune disease. Furthermore, Roehrl's laboratory is already using the new discoveries to develop personalized molecular serum testing for patients with autoimmune diseases, an area of medicine that "has not seen significant advances in a very long time and that was ripe for a real breakthrough" according to Roehrl.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers report widespread use of medications among pregnant women
2. Couch-Potato Kids: It Shows in Their Eyes, Researchers Say
3. Antidepressants may not improve all symptoms of depression, UT Southwestern researchers find
4. Women Taking Calcium Supplements May Risk Heart Health, Researchers Say
5. Limiting carbs, not calories, reduces liver fat faster, UT Southwestern researchers find
6. Mutated gene found in dog disease the same in humans, MU researchers find
7. Researchers inject nanofiber spheres carrying cells into wounds to grow tissue
8. Wistar researchers follow a path to a potential therapy for NF2, a rare tumor disorder
9. Whales Not Just Singing the Same Old Song, Researchers Say
10. Boston University researchers find most substance-dependent individuals report poor oral health
11. University of Granada researchers make the first bioartificial organ in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic access ... and the Delaware Health Information Network (DHIN) have partnered to improve connectivity of ... health information exchange, DHIN stores and shares real-time health data for more than ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews ... and other Butler products. Ken was impressed with the safety and reliability of ... the product on his show. This endorsement by Ken Matthews can be heard ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action ... Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ... action (CA) and preventive action (PA)? , The methods share techniques and tools ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, ... to grow at a CAGR of 9.4% from 2017-2022 and CAGR ... a CAGR of 9.5% from 2017 to 2027. The market is ... ... you Read on to discover how you can exploit the ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance Biopharma, ... or the "Company") today announced the presentation of ... and orally administered pan-Janus kinase (JAK) inhibitor designed ... Congress of the European Crohn,s and Colitis ... reported further data from its completed Phase 1 ...
(Date:2/17/2017)...   Risperdal lawsuits involving gynecomastia (male breast growth) ... of the atypical antipsychotic medication continue to move forward ... Common Pleas, where the state,s Risperdal docket has been ... notice posted on the Court,s website , the ... 9, 2017 at 11:00 a.m. (In Re: Risperdal Litigation, ...
Breaking Medicine Technology: